ANIP 56.91 (+1.88%)
US00182C1036• Drug Manufacturers• Drug Manufacturers - Specialty & Generic
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. ANIP

ANI Pharmaceuticals (ANIP) Competitor Comparison

We are evaluating the key criteria listed to compare ANI Pharmaceuticals (ANIP) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Market Capitalization

19 / 54

Gross Profits

22 / 39

Total Revenue

24 / 50

EBITDA

18 / 53

Free Cashflow

17 / 54

Quick Ratio

13 / 54

Earnings per Share

7 / 54

Dividend yield

0 / 5

Total Cash

17 / 54

Performance 3 years

9 / 54

Performance 5 years

18 / 54

Performance 10 years

14 / 54

Linearity 3 years

11 / 54

Linearity 5 years

5 / 54

Linearity 10 years

1 / 54

Total Rank

27 / 54

Dividend Rank

45 / 54

Valuation Rank

47 / 54

Piotroski Rank

23 / 54

Muliplier Rank

34 / 54

Dividend yield - ANIP ranking 0 / 5

These are the competitors of ANI Pharmaceuticals in the industry Drug Manufacturers - Specialty & Generic ranked by dividend yield
1. Linc LNC
5.1
2. Perrigo PRGO
4.1
3. Embecta EMBC
3.92
4. Phibro Animal Health PAHC
2.04
5. Zoetis ZTS
0.98
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.